Microplate ELISA for urine microalbumin: Reference values and results in patients with type 2 diabetes and cardiovascular disease

Annals of Clinical and Laboratory Science

Volumn 35, Issue 2, 2005, Pages 149-154

  Wu, Tsu Lan ^a,b   Chang, Pi Yueh ^a   Li, Chia Chi ^a   Tsao, Kuo Chien ^a   Sun, Chien Feng ^a   Wu, James T ^b  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b ARUP LABORATORIES   (United States)

Author keywords

Cardiovascular disease; Enzyme linked immunosorbent assay; Microtiter plate assay; Type 2 diabetes; Urine microalbumin

Indexed keywords

ALBUMIN; ANTIBODY; MICROALBUMIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ASSAY; AUTOANALYZER; CARDIOVASCULAR DISEASE; CHINESE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REFERENCE VALUE; SENSITIVITY ANALYSIS; URINALYSIS; URINE;

ALBUMINS; ALBUMINURIA; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; REFERENCE VALUES; URINALYSIS;

ARMORACIA RUSTICANA;

EID: 18744373899     PISSN: 00917370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. NEJM 1984;310:356-360.
2. Le Floch JP, Marre M, Rodier M, Passa P. Interest of Clinitek microalbumin in screening for microalbuminuria: results of a multicentre study in 302 diabetic patients. Diabetes Metab 2001;27:36-39.
3. Mogensen CE, Hansen KW, Sommer S, Klebe J, Christensen CK Marshall S, et al. Microalbuminuria: studies in diabetes, essential hypertension, and renal diseases as compared with the background population. Adv Nephrol 1991;20:191-228.
4. Ritz E. Albuminuria and vascular damage - the vicious twins. Editorials. NEJM 2003;348:2349-2352.
5. Perkins BA, Ficociello LH, Silva KH, Finkelstein DM, Warram JH, Krolewski AS. Regression of microalbuminuria in type 1 diabetes. NEJM 2003;348:2285-2293.
6. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE, Wareham NJ. Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. Int J Epidemiol 2004;33:189-198.
7. Pedersen LM, Bergmann OJ. Urinary albumin excretion and its relationship to C-reactive protein and proinflammatory cytokines in patients with cancer and febrile neutropenia. Scand J Infect Dis 2003;35:491-494.
8. Nathan C. Points of control in inflammation. Nature 2002;420:846-852.
9. Pedersen LM, Sorensen PG. Mediators of inflammation correlate with microalbuminuria in patients with non-Hodgkin's lymphoma. Br J Haematol 2003;121:275-279.
10. Stuveling EM, Hillege HL, Bakker SJ, Asselbergs FW, de Jong PE, Gans RO, de Zeeuw D; PREVEND study group. C-reactive protein and microalbuminuria differ in their associations with various domains of vascular disease. Atherosclerosis. 2004;172:107-114.
11. Roberts WL, Calcote CB, Cook CB, Gordon DL, Moore ML, Moore S, Scheer WD, Snazelle BA. Comparison of four commercial urinary albumin (microalbumin) methods: implications for detecting diabetic nephropathy using random urine specimens. Clin Chim Acta 1998;273:21-23.
12. Wu JT, Wu LL. Detection of miroalbuminuria: electro-immunodiffusion (rocket), radioimmunodiffusion (RID), and microplate enzyme immunoassay. In: Laboratory Diagnosis of Metabolic Disorders with Emphasis on Diabetes Mellitus (FW Sunderman, Ed), Institute for Clinical Science, Philadelphia, 1992; pp 85-93.
13. Flieding BA, Price DA, Houlton CA. Enzyme immunoassay for urinary albumin. Clin Chem 1983;29:355-357.